Pro# M06-873: A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date7/27/095/31/13

Funding

  • Abbott Laboratories (M06-873)